- Home
- OKTA vs GH Comparison
OKTA vs GH Comparison
Compare OKTA & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OKTA | GH |
|---|---|---|
| Founded | 2009 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6B | 17.3B |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | OKTA | GH |
|---|---|---|
| Price | $116.34 | $131.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 36 | 19 |
| Target Price | $103.60 | ★ $119.79 |
| AVG Volume (30 Days) | ★ 4.5M | 2.3M |
| Earning Date | 05-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2083.33 | 6.74 |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $2,919,000,000.00 | $982,021,000.00 |
| Revenue This Year | $11.27 | $33.30 |
| Revenue Next Year | $9.36 | $28.27 |
| P/E Ratio | $280.05 | ★ N/A |
| Revenue Growth | 11.84 | ★ 32.88 |
| 52 Week Low | $62.66 | $40.36 |
| 52 Week High | $142.35 | $134.28 |
Technical Indicators
Market Signals| Indicator | OKTA | GH |
|---|---|---|
| Relative Strength Index (RSI) | 60.38 | 68.01 |
| Support Level | $73.08 | $97.16 |
| Resistance Level | $142.35 | $134.28 |
| Average True Range (ATR) | 7.27 | 6.52 |
| MACD | -0.62 | -0.42 |
| Stochastic Oscillator | 51.48 | 84.46 |
Price Performance
Historical ComparisonAbout OKTA Okta Inc.
Okta is a cloud-native security company specializing in identity and access management. The San Francisco-based firm went public in 2017 and serves two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees, contractors, and partners to securely access its cloud-based and on-premises resources. The firm's customer offering, delivered via its Auth0 platform, allow clients to provide secure access experiences to their own end users.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.